Compugen Analyst Ratings
Compugen Analyst Ratings
While ratings are subjective and will change, the latest Compugen (CGEN) rating was a reiterated with a price target of $0.00 to $13.00. The current price Compugen (CGEN) is trading at is $1.03, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/07/2023 | 1162.14% | EF Hutton | → $13 | Reiterates | Buy → Buy |
| 06/06/2023 | 1162.14% | EF Hutton | → $13 | Reiterates | → Buy |
| 05/26/2023 | 1162.14% | EF Hutton | → $13 | Reiterates | Buy → Buy |
| 05/24/2023 | 1162.14% | EF Hutton | → $13 | Reiterates | Buy → Buy |
| 05/16/2023 | 579.61% | Oppenheimer | $8 → $7 | Maintains | Outperform |
| 02/28/2023 | 676.7% | Oppenheimer | → $8 | Reiterates | → Outperform |
| 02/08/2023 | -51.46% | Jefferies | → $0.5 | Downgrades | Hold → Underperform |
| 01/05/2023 | 1162.14% | EF Hutton | → $13 | Initiates Coverage On | → Buy |
| 11/15/2022 | 676.7% | Oppenheimer | $12 → $8 | Maintains | Outperform |
| 08/23/2022 | 288.35% | Truist Securities | $14 → $4 | Maintains | Buy |
| 08/08/2022 | 288.35% | JMP Securities | $8 → $4 | Maintains | Market Outperform |
| 08/08/2022 | 1065.05% | Oppenheimer | $14 → $12 | Maintains | Outperform |
| 08/05/2022 | 94.17% | Jefferies | → $2 | Downgrades | Buy → Hold |
| 02/25/2022 | 1259.22% | Oppenheimer | $17 → $14 | Maintains | Outperform |
| 02/25/2022 | 773.79% | SVB Leerink | $16 → $9 | Maintains | Outperform |
| 04/06/2021 | 1453.4% | SVB Leerink | $19 → $16 | Maintains | Outperform |
| 08/19/2020 | 1744.66% | SVB Leerink | $15 → $19 | Maintains | Outperform |
| 05/13/2020 | 1744.66% | Stifel | → $19 | Initiates Coverage On | → Buy |
| 05/07/2020 | 1356.31% | SVB Leerink | → $15 | Initiates Coverage On | → Outperform |
| 04/22/2020 | 2618.45% | Roth Capital | → $28 | Initiates Coverage On | → Buy |
| 03/24/2020 | 1453.4% | SunTrust Robinson Humphrey | → $16 | Initiates Coverage On | → Buy |
| 02/21/2020 | 1162.14% | Cantor Fitzgerald | $10 → $13 | Reiterates | → Overweight |
| 01/16/2020 | 870.87% | Cantor Fitzgerald | → $10 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/07/2023 | 1162.14% | EF Hutton | → 13 美元 | 重申 | 購買 → 購買 |
| 06/06/2023 | 1162.14% | EF Hutton | → 13 美元 | 重申 | → 購買 |
| 05/26/2023 | 1162.14% | EF Hutton | → 13 美元 | 重申 | 購買 → 購買 |
| 05/24/2023 | 1162.14% | EF Hutton | → 13 美元 | 重申 | 購買 → 購買 |
| 05/16/2023 | 579.61% | 奧本海默 | 8 美元 → 7 美元 | 維護 | 跑贏大盤 |
| 02/28/2023 | 676.7% | 奧本海默 | → 8 美元 | 重申 | → 跑贏大盤 |
| 02/08/2023 | -51.46% | 傑富瑞 | → 0.5 美元 | 降級 | 持有 → 表現不佳 |
| 01/05/2023 | 1162.14% | EF Hutton | → 13 美元 | 啓動覆蓋開啓 | → 購買 |
| 11/15/2022 | 676.7% | 奧本海默 | 12 美元 → 8 美元 | 維護 | 跑贏大盤 |
| 2022 年 8 月 23 日 | 288.35% | 信託證券 | 14 美元 → 4 美元 | 維護 | 購買 |
| 08/08/2022 | 288.35% | JMP 證券 | 8 美元 → 4 美元 | 維護 | 市場表現跑贏大盤 |
| 08/08/2022 | 1065.05% | 奧本海默 | 14 美元 → 12 美元 | 維護 | 跑贏大盤 |
| 08/05/2022 | 94.17% | 傑富瑞 | → 2 美元 | 降級 | 買入 → 持有 |
| 2022 年 2 月 25 日 | 1259.22% | 奧本海默 | 17 美元 → 14 美元 | 維護 | 跑贏大盤 |
| 2022 年 2 月 25 日 | 773.79% | SVB Leerink | 16 美元 → 9 美元 | 維護 | 跑贏大盤 |
| 04/06/2021 | 1453.4% | SVB Leerink | 19 美元 → 16 美元 | 維護 | 跑贏大盤 |
| 2020 年 8 月 19 日 | 1744.66% | SVB Leerink | 15 美元 → 19 美元 | 維護 | 跑贏大盤 |
| 05/13/2020 | 1744.66% | Stifel | → 19 美元 | 啓動覆蓋開啓 | → 購買 |
| 05/07/2020 | 1356.31% | SVB Leerink | → 15 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
| 2020 年 4 月 22 日 | 2618.45% | 羅斯資本 | → 28 美元 | 啓動覆蓋開啓 | → 購買 |
| 2020 年 3 月 24 日 | 1453.4% | SunTrust 羅賓遜漢弗萊 | → 16 美元 | 啓動覆蓋開啓 | → 購買 |
| 02/21/2020 | 1162.14% | 坎託·菲茨傑拉德 | 10 美元 → 13 美元 | 重申 | → 超重 |
| 2020 年 1 月 16 日 | 870.87% | 坎託·菲茨傑拉德 | → 10 美元 | 啓動覆蓋開啓 | → 超重 |
What is the target price for Compugen (CGEN)?
Compugen (CGEN) 的目標價格是多少？
The latest price target for Compugen (NASDAQ: CGEN) was reported by EF Hutton on August 7, 2023. The analyst firm set a price target for $13.00 expecting CGEN to rise to within 12 months (a possible 1162.14% upside). 12 analyst firms have reported ratings in the last year.
EF Hutton於2023年8月7日公佈了Compugen（納斯達克股票代碼：CGEN）的最新目標股價。這家分析公司將目標股價定爲13.00美元，預計CGEN將在12個月內升至12個月內（可能上漲1162.14％）。去年有12家分析公司公佈了評級。
What is the most recent analyst rating for Compugen (CGEN)?
分析師對Compugen（CGEN）的最新評級是多少？
The latest analyst rating for Compugen (NASDAQ: CGEN) was provided by EF Hutton, and Compugen reiterated their buy rating.
Compugen（納斯達克股票代碼：CGEN）的最新分析師評級由EF Hutton提供，Compugen重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Compugen (CGEN)?
Compugen（CGEN）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Compugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Compugen was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Compugen的高管和客戶交談以及聽取業績電話會議）後得出了股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Compugen的最後一次評級是在2023年8月7日提交的，因此您應該預計下一個評級將在2024年8月7日左右公佈。
Is the Analyst Rating Compugen (CGEN) correct?
分析師對Compugen（CGEN）的評級正確嗎？
While ratings are subjective and will change, the latest Compugen (CGEN) rating was a reiterated with a price target of $0.00 to $13.00. The current price Compugen (CGEN) is trading at is $1.03, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的Compugen（CGEN）評級得到了重申，目標股價爲0.00美元至13.00美元。Compugen（CGEN）目前的交易價格爲1.03美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。
